NumerixS Investment Technologies’s Acadia Pharmaceuticals ACAD Stock Holding History

NumerixS Investment Technologies’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-11,501	Closed	-$557K	–	10
2020 Q2	$557K	Buy	11,501 +9,401	+448%	+$451K	0.16%	149
2020 Q1	$89K	Buy	+2,100	New	+$86.5K	0.05%	457
2019 Q4	–	Sell	-6,798	Closed	-$245K	–	1020
2019 Q3	$245K	Buy	6,798 +2,798	+70%	+$84.8K	0.06%	329
2019 Q2	$107K	Buy	+4,000	New	+$102K	0.03%	588
2018 Q3	–	Sell	-13,500	Closed	-$203K	–	1167
2018 Q2	$203K	Buy	13,500 +5,600	+71%	+$99.9K	0.05%	518
2018 Q1	$183K	Buy	+7,900	New	+$219K	0.05%	434
2017 Q4	–	Sell	-3,600	Closed	-$136K	–	1098
2017 Q3	$136K	Buy	+3,600	New	+$117K	0.03%	643
2016 Q3	–	Sell	-6,086	Closed	-$198K	–	1087
2016 Q2	$198K	Buy	+6,086	New	+$204K	0.03%	702
2015 Q2	–	Sell	-20,047	Closed	-$653K	–	611
2015 Q1	$653K	Buy	+20,047	New	+$689K	0.12%	240

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

NumerixS Investment Technologies's ACAD Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of Acadia Pharmaceuticals (ACAD) in Q3 2020, closing a stake of 11,501 shares — an estimated $557K sold.

NumerixS Investment Technologies first reported a position in ACAD in Q1 2015 and held it in 9 quarters. The position peaked at $653K in Q1 2015. 266 funds tracked by Wall St. Rank hold ACAD as of Q3 2020.

NumerixS Investment Technologies reported no remaining Acadia Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
NumerixS Investment Technologies sold 11,501 Acadia Pharmaceuticals shares in Q3 2020, an estimated $557K.
NumerixS Investment Technologies first reported a position in Acadia Pharmaceuticals in Q1 2015 and held it in 9 quarters.
NumerixS Investment Technologies's Acadia Pharmaceuticals position peaked at $653K in Q1 2015.
266 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.